BioSpace News Archive

Drug Development

Neurotrope’s Bryostatin Improves Cognition in Patients With Advanced Alzheimer’s Disease Based on Further Analysis of Phase II Clinical Trial Data

The findings suggest this investigational drug could potentially help treat the progression of AD, rather than only its symptoms.

January 5, 2018
·
9 min read
Business

OrthoPediatrics Corp. Announces Preliminary Revenue for Fourth Quarter and Full Year 2017

OrthoPediatrics’ preliminary unaudited full year 2017 revenue is expected to be in the range of $45.4 million to $45.6 million, representing annual growth of 22%.

January 5, 2018
·
1 min read
Business

Natus Appoints Leslie McDonnell as Vice President and General Manager of Its Newborn Care Business Unit

Ms. McDonnell will report to Jim Hawkins, CEO, and will be responsible for leading and expanding Natus’ newborn care business.

January 5, 2018
·
1 min read
Bio NC

Novan Announces Pricing of $38M Offering of Common Stock and Warrants

Piper Jaffray & Co. is acting as the sole manager for the offering.

January 5, 2018
·
2 min read
Drug Development

Minoryx Therapeutics Announces the Dosing of First Patient in ADVANCE, a Phase II/III Clinical Study of MIN-102 in Patients With Adrenomyeloneuropathy (AMN)

The trial enrolls adult male patients affected by AMN, the most frequent phenotype of X-linked adrenoleukodystrophy.

January 5, 2018
·
5 min read
Business

Advanced Bifurcation Systems Announces Scott King Joins as Chief of Compliance Ahead of FDA Application

ABS Scott King has joined the leadership team as VP of Regulatory Affairs.

January 5, 2018
·
2 min read
GeneNews Announces Letter to Shareholders From CEO

GeneNews released a Letter to Shareholders updating current activities and outlining its corporate strategy for 2018.

January 5, 2018
·
4 min read
Biotech Bay

ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study

ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study.

January 5, 2018
·
3 min read
Biotech Beach

NantKwest to Host 3rd Annual Investor/Analyst Day Highlighting a Record Number of 15 INDs Authorized in 2017 Covering 12 Tumor Types with First In-Human Clinical Data of Safety and Early Signs of Clinical Activity of the NANT Cancer Vaccine

NantKwest announced today that the company will be hosting an Investor/Analyst Day on Tuesday, January 9th in San Francisco, California.

January 5, 2018
·
3 min read
Business

Datavant Integrates 150th Data Source and Announces Academic Partnership With Duke

Datavant today announced the integration of its 150th dataset, and named the DCRI as its Founding Academic Partner.

January 5, 2018
·
3 min read